New technology to measure radiation exposure in pilots

July 17, 2013

(Medical Xpress)—Researchers from the University of Wollongong have developed a unique device that measures how much radiation pilots and astronauts are exposed to.

The silicon-based microdosimeter assesses the to astronauts and pilots, and to microelectronics, during long-term and high altitude flights.

Exposure to too much radiation can cause cancer, damage to the foetuses of pregnant women and genetic defects that can be passed onto future generations.

Professor Anatoly Rozenfeld, Director of the Centre for Medical Radiation Physics (CMRP) – the largest research body of its kind in the Asia Pacific region – has just been granted a US patent for his invention.

"Silicon microdosimetry is providing a new metric for the estimation of hazards from in mixed radiation fields. It is an essential contribution to of pilots and astronauts in avionics and space, where the radiation environment is not easy to predict," Professor Rozenfeld said.

Professor Rozenfeld and his multidisciplinary research team at CMRP have worked with a number of high profile international agencies, such as the National Space Biomedical Research Institute (USA), the United States Naval Academy, the Australian Nuclear Science and Technology Organisation (ANTSO) and the Australian National Fabrication Facility at UNSW, on the invention.

"We are confident that this version of 3D silicon microdosimeter after final investigation of prototype will be very attractive for commercialisation in many fields of terrestrial and protection," Professor Rozenfeld said.

Professor Rozenfeld, who has dedicated his life to finding better treatments for cancer after losing both parents to the disease, said the technology could also be used in advanced modalities (such as proton and heavy ion therapies) for cancer treatment.

Professor Rozenfeld also recently received a Chinese patent for a skin dosimetry technology that was 10 years in the making.

'Drop-in' accurately measures (in real time) the amount of radiation absorbed into a patient's skin during procedures such as radiotherapy and CT scans that can give off high levels of ionising radiation.

"An accurate skin dose measurement can help prevent a patient's skin from being overdosed, and at the same time, provide a vital indication of overall radiation safety," Professor Rozenfeld said.

Explore further: Researchers provide prospective on low-dose radiation biology controversy

Related Stories

Researchers provide prospective on low-dose radiation biology controversy

May 14, 2013
A review of the current issues in low-dose radiation research authored by two radiation biologists from the Pacific Northwest National Laboratory is the cover story of the May 2013 issue of Radiation Research. The review, ...

New technology reduces, controls CT radiation exposure in children

June 19, 2013
Patients at Cincinnati Children's Hospital Medical Center are being exposed to significantly less radiation during CT scans because of new technology that allows doctors to more tightly control radiation doses. The first-of-its-kind ...

Biodegradable implant may lessen side effects of radiation to treat prostate cancer

June 10, 2013
Several years ago, Virginia Commonwealth University Massey Cancer Center became the first center in the United States to test an Israeli-invented device designed to increase the space between the prostate and the rectum in ...

Chest radiation cancer patients with risk factors should have CV screening every 5-10 years

July 16, 2013
Sophia Antipolis, 16 July 2013: Cancer patients who receive chest radiation should be screened for heart disease every 5-10 years, according to the European Association of Cardiovascular Imaging (EACVI) of the European Society ...

Exposure to space radiation reduces ability of intestinal cells to destroy oncoprotein

April 9, 2013
Two studies funded by NASA and presented at the AACR Annual Meeting 2013 help explain why space radiation may increase the risk of colorectal cancer in humans.

Silicone dressings reduce painful skin reactions following radiation for breast cancer, study finds

November 1, 2012
(Medical Xpress)—Skin reactions following radiation therapy for breast cancer have been the focus of a recent clinical trial conducted by Dr Patries Herst from the Department of Radiation Therapy, University of Otago, Wellington ...

Recommended for you

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.